BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18790648)

  • 1. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
    Georgiadis D; Yiotakis A
    Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular regulation of metalloproteinases.
    Yamamoto K; Murphy G; Troeberg L
    Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
    Murphy G
    Int J Exp Pathol; 2010 Aug; 91(4):303-13. PubMed ID: 20666850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.
    Bekhouche M; Kronenberg D; Vadon-Le Goff S; Bijakowski C; Lim NH; Font B; Kessler E; Colige A; Nagase H; Murphy G; Hulmes DJ; Moali C
    J Biol Chem; 2010 May; 285(21):15950-9. PubMed ID: 20207734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional proteomics on zinc-dependent metalloproteinases using inhibitor probes.
    Klein T; P Geurink P; S Overkleeft H; K Kauffman H; Bischoff R
    ChemMedChem; 2009 Feb; 4(2):164-70. PubMed ID: 19072819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic active site-directed inhibitors of metzincins: achievement and perspectives.
    Yiotakis A; Dive V
    Mol Aspects Med; 2008 Oct; 29(5):329-38. PubMed ID: 18657570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases: fold and function of their catalytic domains.
    Tallant C; Marrero A; Gomis-Rüth FX
    Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
    Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
    Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.
    Lukacova V; Zhang Y; Kroll DM; Raha S; Comez D; Balaz S
    J Med Chem; 2005 Apr; 48(7):2361-70. PubMed ID: 15801829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders.
    Brzdak P; Nowak D; Wiera G; Mozrzymas JW
    Front Cell Neurosci; 2017; 11():178. PubMed ID: 28713245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and spectroscopic study of reactions between chelating zinc-binding groups and mimics of the matrix metalloproteinase and disintegrin metalloprotease catalytic sites: the coordination chemistry of metalloprotease inhibition.
    He H; Puerta DT; Cohen SM; Rodgers KR
    Inorg Chem; 2005 Oct; 44(21):7431-42. PubMed ID: 16212369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic remodeling of the synaptic cell adhesion molecules (CAMs) by metzincins in synaptic plasticity.
    Bajor M; Kaczmarek L
    Neurochem Res; 2013 Jun; 38(6):1113-21. PubMed ID: 23124395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMPs and ADAMTSs: functional studies.
    Flannery CR
    Front Biosci; 2006 Jan; 11():544-69. PubMed ID: 16146752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.